{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:05:40Z","timestamp":1777536340584,"version":"3.51.4"},"reference-count":63,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"unspecified","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2020,8,31]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>The sharing of clinical trial data and biomarker data sets among the scientific community, whether the data originates from pharmaceutical companies or academic institutions, is of critical importance to enable the development of new and improved cancer immunotherapy modalities. Through data sharing, a better understanding of current therapies in terms of their efficacy, safety and biomarker data profiles can be achieved. However, the sharing of these data sets involves a number of stakeholder groups including patients, researchers, private industry, scientific journals and professional societies. Each of these stakeholder groups has differing interests in the use and sharing of clinical trial and biomarker data, and the conflicts caused by these differing interests represent significant obstacles to effective, widespread sharing of data. Thus, the Society for Immunotherapy of Cancer (SITC) Biomarkers Committee convened to identify the current barriers to biomarker data sharing in immuno-oncology (IO) and to help in establishing professional standards for the responsible sharing of clinical trial data. The conclusions of the committee are described in two position papers: Volume I\u2014conceptual challenges and Volume II\u2014practical challenges, the first of which is presented in this manuscript. Additionally, the committee suggests actions by key stakeholders in the field (including organizations and professional societies) as the best path forward, encouraging the cultural shift needed to ensure responsible data sharing in the IO research setting.<\/jats:p>","DOI":"10.1136\/jitc-2020-001389","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T17:06:00Z","timestamp":1604077560000},"page":"e001389","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I\u2014conceptual challenges"],"prefix":"10.1136","volume":"8","author":[{"given":"Sergio","family":"Rutella","sequence":"first","affiliation":[{"name":"John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, Nottinghamshire, UK"},{"name":"Centre for Health, Ageing and Understanding Disease (CHAUD), Nottingham Trent University, Nottingham, Nottinghamshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A","family":"Cannarile","sequence":"additional","affiliation":[{"name":"Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Penzberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sacha","family":"Gnjatic","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Gomes","sequence":"additional","affiliation":[{"name":"Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Guinney","sequence":"additional","affiliation":[{"name":"Sage Bionetworks, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaios","family":"Karanikas","sequence":"additional","affiliation":[{"name":"Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"Karkada","sequence":"additional","affiliation":[{"name":"Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M","family":"Kirkwood","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/ Oncology, University of Pittsburgh School of Medicine and Melanoma Center at UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrix","family":"Kotlan","sequence":"additional","affiliation":[{"name":"National Institute of Oncology, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe V","family":"Masucci","sequence":"additional","affiliation":[{"name":"Department Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"Meeusen","sequence":"additional","affiliation":[{"name":"CancerProbe Pty Ltd, Prahran, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Monette","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-8513","authenticated-orcid":false,"given":"Aung","family":"Naing","sequence":"additional","affiliation":[{"name":"Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9steinn","family":"Thorsson","sequence":"additional","affiliation":[{"name":"Institute for Systems Biology, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Tschernia","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ena","family":"Wang","sequence":"additional","affiliation":[{"name":"Allogene Therapeutics, South San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel K","family":"Wells","sequence":"additional","affiliation":[{"name":"Parker Institute for Cancer Immunotherapy, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy L","family":"Wyant","sequence":"additional","affiliation":[{"name":"Biolojic Design Inc, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Cesano","sequence":"additional","affiliation":[{"name":"ESSA Pharma Inc, South San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"2025100308205080000_8.2.e001389.1","doi-asserted-by":"crossref","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025100308205080000_8.2.e001389.2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/JIPO.JIPO_20_18","article-title":"Being realistic and optimistic in curing cancer","volume":"1","author":"Naing","year":"2018","journal-title":"J Immunother Precis Oncol"},{"key":"2025100308205080000_8.2.e001389.3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fmed.2019.00119","article-title":"Biomarkers for immune checkpoint inhibitor-mediated tumor response and adverse events","volume":"6","author":"Nakamura","year":"2019","journal-title":"Front Med"},{"key":"2025100308205080000_8.2.e001389.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0116-x"},{"key":"2025100308205080000_8.2.e001389.5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","article-title":"Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma","volume":"24","author":"Auslander","year":"2018","journal-title":"Nat Med"},{"key":"2025100308205080000_8.2.e001389.6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.23838\/pfm.2019.00079","article-title":"Combined biomarker for prediction of response to an immune checkpoint inhibitor in metastatic gastric cancer","volume":"3","author":"Heo","year":"2019","journal-title":"Precis Future Med"},{"key":"2025100308205080000_8.2.e001389.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0686-0"},{"key":"2025100308205080000_8.2.e001389.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g237"},{"key":"2025100308205080000_8.2.e001389.9","doi-asserted-by":"publisher","DOI":"10.1177\/1556264615594606"},{"key":"2025100308205080000_8.2.e001389.10","doi-asserted-by":"publisher","DOI":"10.1177\/1556264615594767"},{"key":"2025100308205080000_8.2.e001389.11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2217\/cer-2017-0009","article-title":"Stakeholders\" views on data sharing in multicenter studies","volume":"6","author":"Mazor","year":"2017","journal-title":"J Comp Eff Res"},{"key":"2025100308205080000_8.2.e001389.12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-1144"},{"key":"2025100308205080000_8.2.e001389.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12911-016-0325-0","article-title":"Legal assessment tool (LAT): an interactive tool to address privacy and data protection issues for data sharing","volume":"16","author":"Kuchinke","year":"2016","journal-title":"BMC Med Inform Decis Mak"},{"key":"2025100308205080000_8.2.e001389.14","doi-asserted-by":"crossref","first-page":"e001550","DOI":"10.1136\/bmjgh-2019-001550","article-title":"It is not enough that we require data to be shared; we have to make sharing easy, feasible and accessible too!","volume":"4","author":"Hajduk","year":"2019","journal-title":"BMJ Glob Health"},{"key":"2025100308205080000_8.2.e001389.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)302518"},{"key":"2025100308205080000_8.2.e001389.16","unstructured":"Nextstrain . All SARS-CoV-2 situation reports. Available: https:\/\/nextstrain.org\/ncov-sit-reps"},{"key":"2025100308205080000_8.2.e001389.17","unstructured":"Global Initiative on Sharing all Influenza Data . Genomic epidemiology of hCoV-19. Available: https:\/\/www.gisaid.org\/epiflu-applications\/next-hcov-19-app\/"},{"key":"2025100308205080000_8.2.e001389.18","unstructured":"Johns Hopkins University . Coronavirus resource center. Available: https:\/\/coronavirus.jhu.edu\/"},{"key":"2025100308205080000_8.2.e001389.19","unstructured":"Worldometer . COVID-19 coronavirus pandemic. Available: https:\/\/www.worldometers.info\/coronavirus\/"},{"key":"2025100308205080000_8.2.e001389.20","unstructured":"Healthmap . COVID-19. Available: https:\/\/healthmap.org\/covid-19\/"},{"key":"2025100308205080000_8.2.e001389.21","unstructured":"Our World in Data . Coronavirus pandemic (COVID-19). Available: https:\/\/ourworldindata.org\/coronavirus"},{"key":"2025100308205080000_8.2.e001389.22","unstructured":"World Health Organization . Coronavirus disease (COVID-19) pandemic. Available: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019"},{"key":"2025100308205080000_8.2.e001389.23","unstructured":"World Health Organization . COVID-19 global literature on coronavirus disease. Available: https:\/\/search.bvsalud.org\/global-literature-on-novel-coronavirus-2019-ncov\/"},{"key":"2025100308205080000_8.2.e001389.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31187-9"},{"key":"2025100308205080000_8.2.e001389.25","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.18_suppl.LBA110","article-title":"Clinical impact of COVID-19 on patients with cancer: data from the COVID-19 and cancer Consortium (CCC19)","volume":"38","author":"Warner","year":"2020","journal-title":"JCO"},{"key":"2025100308205080000_8.2.e001389.26","unstructured":"The Society for Immunotherapy of Cancer . SITC Advocates for scientific journals to grant open access to COVID-19 publications. Available: https:\/\/www.sitcancer.org\/research\/covid-19-resources\/open-access"},{"key":"2025100308205080000_8.2.e001389.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"2025100308205080000_8.2.e001389.28","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507"},{"key":"2025100308205080000_8.2.e001389.29","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-0319-0","article-title":"Advancing scientific knowledge in times of pandemics","volume":"20","author":"Vabret","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2025100308205080000_8.2.e001389.30","unstructured":"Human immune monitoring center at Mount Sinai, Fernandez N. reviewing COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv. Available: https:\/\/observablehq.com\/@ismms-himc\/covid-19-sars-cov-2-preprints-from-medrxiv-and-biorxiv"},{"key":"2025100308205080000_8.2.e001389.31","doi-asserted-by":"publisher","DOI":"10.7326\/M18-2854"},{"key":"2025100308205080000_8.2.e001389.32","unstructured":"U.S. Food and Drug Administration . Institutional review boards frequently asked questions, 1998. Available: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/institutional-review-boards-frequently-asked-questions"},{"key":"2025100308205080000_8.2.e001389.33","unstructured":"European Patients\" Academy . Research ethics committees (rec). Available: https:\/\/www.eupati.eu\/clinical-development-and-trials\/research-ethics-committees-rec\/"},{"key":"2025100308205080000_8.2.e001389.34","doi-asserted-by":"publisher","DOI":"10.1054\/nedt.1999.0349"},{"key":"2025100308205080000_8.2.e001389.35","unstructured":"Tene O , Polonetsky J . Big data for all: privacy and user control in the age of analytics. Northwest J Technol Intellect Prop 2012;11."},{"key":"2025100308205080000_8.2.e001389.36","doi-asserted-by":"crossref","unstructured":"Politou E , Alepis E , Patsakis C . Forgetting personal data and revoking consent under the GDPR: challenges and proposed solutions. J Cybersecur 2018;4.doi:10.1093\/cybsec\/tyy001","DOI":"10.1093\/cybsec\/tyy001"},{"key":"2025100308205080000_8.2.e001389.37","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-082410-101454"},{"key":"2025100308205080000_8.2.e001389.38","unstructured":"Metcalf J , Keller E , Boyd D . Perspectives on big data, ethics, and society, 2016. Available: https:\/\/bdes.datasociety.net\/council-output\/perspectives-on-big-data-ethics-and-society\/"},{"key":"2025100308205080000_8.2.e001389.39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.292"},{"key":"2025100308205080000_8.2.e001389.40","unstructured":"Harris L . Understanding corporate data sharing decisions: practices, challenges, and opportunities for sharing corporate data with researchers, 2017. Available: https:\/\/fpf.org\/2017\/11\/14\/understanding-corporate-data-sharing-decisions-practices-challenges-and-opportunities-for-sharing-corporate-data-with-researchers\/"},{"key":"2025100308205080000_8.2.e001389.41","unstructured":"Wouters P , Haak W E , et al . Open Data- the researcher perspective 2018."},{"key":"2025100308205080000_8.2.e001389.42","doi-asserted-by":"publisher","DOI":"10.1093\/jisesa\/iew092"},{"key":"2025100308205080000_8.2.e001389.43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0507655102"},{"key":"2025100308205080000_8.2.e001389.44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsbl708278"},{"key":"2025100308205080000_8.2.e001389.45","doi-asserted-by":"publisher","DOI":"10.1080\/08989621.2019.1591277"},{"key":"2025100308205080000_8.2.e001389.46","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.3208","article-title":"Reproducible and reusable research: are Journal data sharing policies meeting the mark?","volume":"5","author":"Vasilevsky","year":"2017","journal-title":"PeerJ"},{"key":"2025100308205080000_8.2.e001389.47","doi-asserted-by":"crossref","first-page":"160018","DOI":"10.1038\/sdata.2016.18","article-title":"The fair guiding principles for scientific data management and stewardship","volume":"3","author":"Wilkinson","year":"2016","journal-title":"Sci Data"},{"key":"2025100308205080000_8.2.e001389.48","unstructured":"ASH Research Collaborative . Ash rC data hub. Available: https:\/\/www.ashresearchcollaborative.org\/s\/data-hub"},{"key":"2025100308205080000_8.2.e001389.49","unstructured":"AACR . Aacr project genie: Powering precision medicine. Available: https:\/\/www.aacr.org\/professionals\/research\/aacr-project-genie\/"},{"key":"2025100308205080000_8.2.e001389.50","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0453-4"},{"key":"2025100308205080000_8.2.e001389.51","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0225-6"},{"key":"2025100308205080000_8.2.e001389.52","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0178-1"},{"key":"2025100308205080000_8.2.e001389.53","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0179-0"},{"key":"2025100308205080000_8.2.e001389.54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF03165291","article-title":"The International bone marrow transplant registry","volume":"76 Suppl 1","author":"Goldman","year":"2002","journal-title":"Int J Hematol"},{"key":"2025100308205080000_8.2.e001389.55","doi-asserted-by":"crossref","unstructured":"Bortin MM , Rimm AA . Factors influencing success and failure of human marrow transplantation: a review from the International bone marrow transplant registry. New York, NY: Springer New York, 1979.","DOI":"10.1007\/978-1-4612-6179-7_22"},{"key":"2025100308205080000_8.2.e001389.56","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"2025100308205080000_8.2.e001389.57","unstructured":"National Cancer Institute . Tcga research network publications. Available: https:\/\/www.cancer.gov\/about-nci\/organization\/ccg\/research\/structural-genomics\/tcga\/publications"},{"key":"2025100308205080000_8.2.e001389.58","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.cell.2017.04.016","article-title":"An immune atlas of clear cell renal cell carcinoma","volume":"169","author":"Chevrier","year":"2017","journal-title":"Cell"},{"key":"2025100308205080000_8.2.e001389.59","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"key":"2025100308205080000_8.2.e001389.60","unstructured":"National Institutes of Health . Nih data sharing policy and implementation guidance, 2003. Available: https:\/\/grants.nih.gov\/grants\/policy\/data_sharing\/data_sharing_guidance.htm"},{"key":"2025100308205080000_8.2.e001389.61","unstructured":"National Institutes of Health . Nih data sharing policies, 2019. Available: https:\/\/www.nlm.nih.gov\/NIHbmic\/nih_data_sharing_policies.html"},{"key":"2025100308205080000_8.2.e001389.62","unstructured":"European Commission . Horizon 2020, 2020. Available: https:\/\/ec.europa.eu\/programmes\/horizon2020\/en"},{"key":"2025100308205080000_8.2.e001389.63","unstructured":"European Commission, Horizon . H2020 Online Manual: Open access & Data management. Available: https:\/\/ec.europa.eu\/research\/participants\/docs\/h2020-funding-guide\/cross-cutting-issues\/open-access-dissemination_en.htm"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2020-001389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T15:21:06Z","timestamp":1759504866000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2020-001389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,10,30]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/jitc-2020-001389"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2020-001389","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}